M&A Deal Summary

Exo Acquires Medo

On July 26, 2022, Exo acquired information technology company Medo

Acquisition Highlights
  • This is Exo’s 1st transaction in the Information Technology sector.
  • This is Exo’s 1st transaction in Canada.
  • This is Exo’s 1st transaction in Alberta.

M&A Deal Summary
Date 2022-07-26
Target Medo
Sector Information Technology
Buyer(s) Exo
Deal Type Add-on Acquisition

Target

Medo

Edmonton, Alberta, Canada
Medo is a developer of artificial intelligence (AI) technology to make ultrasound imaging faster and simpler to use. The company augments ultrasound with artificial intelligence and cloud computing to bring expert-level on-the-spot diagnosis of ultrasound images to any clinician at point-of-care of a patient. This expertise can range from screening abnormalities in newborn babies at remote locations, monitoring old patients at home, aiding trauma patients in emergency rooms, to diagnosing liver and kidney diseases in family doctor's offices. Medo was formed in 2017 and is based in Edmonton, Alberta.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Exo

Redwood City, California, United States
Category Company
Founded 2015
Sector Medical Products
DESCRIPTION

Exo is a health information and devices company with a mission to modernize medical imaging through its high-performance ultrasound platform and artificial intelligence. Its goal is to enable healthcare professionals to make critical, real-time decisions that ultimately improve patient outcomes. Exo was formed in 2015 and is based in Redwood City, California.

DEAL STATS #
Overall 1 of 1
Sector (Information Technology) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Alberta) 1 of 1
Country (Canada) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal